Breaking News

Thursday, March 26, 2015 - 10:53pm

FDA warns of birth defects with Topamax

FDA warns of birth defects with Topamax
Friday, March 4, 2011 - 3:22pm

WASHINGTON (AP) - The Food and Drug Administration is warning women that using the epilepsy drug Topamax during pregnancy can increase the risk of birth defects around the mouth.

Data shows a higher rate of cleft lip and cleft palate in babies whose mothers were taking the drug during the first trimester.

Topamax is marketed by Johnson & Johnson to control seizures caused by epilepsy, a neurological disorder that causes excessive signals in the brain. The drug is also used to relieve migraine headaches.

J&J and generic drugmakers who market the drug, known as topiramate, will add a stronger warning label about the drug's effect on pregnancies.

Women taking topiramate should talk to their doctor immediately if they become pregnant or are planning to.

Comments News Comments

Post new Comment